Table 9.
Ordered Logistic Regression Models on Higher Likelihood to Choose a New HIV Remission Strategy Over Standard Daily ART Under Scenarios 1–7 (United States, 2018)
|
Increased likelihood of choosing remission strategy over daily ART if… |
||||||
---|---|---|---|---|---|---|---|
No more daily pills, but must go to lab/clinic much more often (e.g., every 2 weeks) [Scenario 1] | No more daily pills, but very small increase in chance of passing HIV on to sex partner [Scenario 2] | New strategy causes worse side effects initially but went away eventually [Scenario 3] | Never take HIV medications again, but very small increase in risk of health problems (e.g., cancer) [Scenario 4] | Uncertainty of new strategy working, but need to stop taking the HIV medication to find out [Scenario 5] | New strategy might not increase life expectancy [Scenario 6] | New strategy might not increase quality of life [Scenario 7] | |
Relatively more risk averse than other participants | 0.97a [0.96–0.99] | 0.97a [0.96–0.99] | 0.97a [0.95–0.98] | 0.96a [0.95–0.98] | 0.97a [0.95–0.98] | 0.98a [0.96–0.99] | 0.96a [0.95–0.98] |
Relatively more motivated by benefits than other participants | 1.04a [1.02–1.05] | 1.02b [1.00–1.03] | 1.03a [1.02–1.05] | 1.02a [1.01–1.03] | 1.01b [1.00–1.03] | 1.01 | 1.02a [1.00–1.03] |
Cis or trans woman (vs. cis man) | 1.29 | 0.90 | 0.55 | 0.95 | 0.90 | 0.65 | 0.53 |
Age | 0.99 | 1.02 | 0.97b [0.94–1.00] | 0.98 | 0.99 | 0.98 | 0.97b [0.94–1.00] |
African American/black (vs. Caucasian/white) | 1.83 | 1.07 | 0.58 | 0.58 | 0.50 | 1.12 | 1.37 |
Other race (vs. Caucasian/white) | 0.95 | 1.26 | 0.56 | 0.84 | 0.83 | 0.49 | 0.45 |
Hispanic | 1.05 | 0.69 | 0.78 | 1.09 | 0.73 | 0.65 | 0.52 |
Some college or 2-year degree (vs. high school diploma) | 0.30b [0.10–0.93] | 0.44 | 2.67 | 1.32 | 2.07 | 1.97 | 1.88 |
4-year college degree (vs. high school diploma) | 0.21b [0.06–0.70] | 0.38 | 0.88 | 1.56 | 0.94 | 1.14 | 1.47 |
Master's or Doctorate degree (vs. high school diploma) | 0.33 | 1.01 | 2.45 | 5.21b [1.39–19.56] | 1.73 | 2.82 | 3.34 |
Married or living with a partner | 1.34 | 0.76 | 0.71 | 1.14 | 0.70 | 0.72 | 0.70 |
Annual household income exceeds $50,000 | 0.73 | 0.70 | 4.48a [1.73–11.57] | 1.98 | 1.32 | 1.60 | 2.37 |
Midwest (vs. Northeast) | 1.44 | 1.15 | 1.44 | 1.14 | 0.96 | 1.51 | 1.25 |
South (vs. Northeast) | 2.37 | 1.83 | 2.31 | 1.78 | 1.58 | 3.01b [1.16–7.76] | 1.97 |
West (vs. Northeast) | 1.79 | 1.26 | 1.89 | 1.41 | 0.82 | 2.03 | 1.49 |
Has a regular, full-time job (vs. no job) | 1.12 | 0.75 | 0.82 | 0.82 | 1.84 | 0.89 | 0.59 |
Has a regular, part-time job (vs. no job) | 0.68 | 0.42 | 1.28 | 0.41 | 1.09 | 0.68 | 0.83 |
Mostly able to pay expenses but late (vs. unable to pay expenses) | 0.91 | 0.60 | 1.02 | 0.90 | 1.51 | 1.59 | 2.49 |
Able to pay expenses, no savings (vs. unable to pay expenses) | 0.81 | 0.84 | 1.31 | 1.20 | 1.53 | 1.69 | 2.26 |
Able to pay expenses, has savings (vs. unable to pay expenses) | 0.84 | 1.31 | 1.19 | 0.66 | 1.13 | 2.04 | 1.99 |
Percentage of lifetime living with HIV or AIDS diagnosis | 0.23 | 0.11b [0.02–0.70] | 0.94 | 0.13b [0.02–0.80] | 0.59 | 0.84 | 0.68 |
Self-assessed health status is in the poorest quartile of participants | 1.05 | 0.78 | 0.94 | 2.10 | 0.87 | 1.67 | 1.37 |
Volunteered for an HIV treatment trial in the past | 0.77 | 1.26 | 2.47b [1.08–5.65] | 1.90 | 2.55b [1.19–5.49] | 3.10a [1.44–6.67] | 3.68a [1.66–8.15] |
Only 0 or 1 pill or tablet of HIV medication per day (vs. more) | 0.63 | 1.16 | 0.95 | 0.37b [0.17–0.83] | 0.67 | 1.14 | 1.03 |
Take HIV medication two or more times per day (vs. once/never) | 1.23 | 4.69a [1.60–13.76] | 0.76 | 0.92 | 0.57 | 0.99 | 1.06 |
HIV medication timing is affected by food/other drugs | 0.93 | 1.58 | 1.44 | 2.22b [1.13–4.37] | 0.90 | 0.47b [0.23–0.94] | 0.70 |
Current HIV medication causes side effects | 0.65 | 0.42b [0.20–0.88] | 0.75 | 0.63 | 0.68 | 0.55 | 0.79 |
n = | 168 | 167 | 168 | 170 | 170 | 168 | 167 |
p = | .0000 | .0008 | .0000 | .0000 | .0004 | .0015 | .0001 |
Psuedo R2 = | 0.1483 | 0.1111 | 0.1557 | 0.1323 | 0.1084 | 0.1012 | 0.1223 |
Numbers in square brackets are the 95% CI of coefficients that are statistically significant at the 5% level.
Statistically significant at 1% level.
Statistically significant at 5% level.